Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients

Invest New Drugs. 2010 Aug;28(4):529-30. doi: 10.1007/s10637-009-9262-4. Epub 2009 May 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Clinical Trials, Phase II as Topic / methods*
  • Dioxoles / therapeutic use*
  • Humans
  • Leiomyosarcoma / drug therapy*
  • Male
  • Middle Aged
  • Neoplasm Metastasis / drug therapy
  • Peritoneal Neoplasms / drug therapy*
  • Tetrahydroisoquinolines / therapeutic use*
  • Trabectedin
  • Treatment Outcome*

Substances

  • Antineoplastic Agents, Alkylating
  • Dioxoles
  • Tetrahydroisoquinolines
  • Trabectedin